| Orphans and Vulnerable Children (OVC) Program |
| | Sponsor: | USAID/Ethiopia Mission, United States Agency for International Development, Ethiopia Mission |
| | Description: | Total Grant Amounts: Anticipated total funding amount is $92,106,320.
The purpose of this Program Description is to define the parameters and results for a new Orphans and Vulnerable Children (OVC) program to improve the accessibility and quality o . . . |
| | | |
| Southern REACH (Regional Expansion of Access and Capacity to Address HIV/AIDS) Grantmaking Initiative |
| | Sponsor: | National AIDS Fund |
| | Description: | Total Grant Amounts: Approximately $1.5 million.
The National AIDS Fund (NAF), with support from the Ford Foundation, has announced the opportunity for grant support through its Southern REACH (Regional Expansion of Access and Capacity to Address H . . . |
| | | |
| MSM Initiative Community Awards - Africa
|
| | Sponsor: | Foundation for AIDS Research |
| | Description: | Total Grant Amounts: Approximately $130,000 is available for this round of awards in Africa.
amfAR, The Foundation for AIDS Research is pleased to announce new funding for projects that address HIV/AIDS among men who have sex with men (MSM) in Afr . . . |
| | | |
| Neuroscience Research on Drug Abuse (R01) |
| | Sponsor: | US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Drug Abuse |
| | Description: | Grant Amounts: Unspecified.
The goals of the research areas described below are to understand the neurobiological mechanisms underlying all phases of drug addiction, including drug withdrawal and relapse, as well as the effects of pharmacological . . . |
| | | |
| Neuroscience Research on Drug Abuse (R21)
|
| | Sponsor: | US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Drug Abuse |
| | Description: | Grant Amounts: Unspecified.
The goals of the research areas described below are to understand the neurobiological mechanisms underlying all phases of drug addiction, including drug withdrawal and relapse, as well as the effects of pharmacological . . . |
| | | |
 Locate more funding announcements
|
